• About
  • Contact
Thursday, May 15, 2025
No Result
View All Result
Londoner News
  • Home
  • London
  • Britain
  • Europe
  • America
  • International
  • Submit Article
  • Other
    • Health
    • Tech
    • Travel
    • Science
  • Home
  • London
  • Britain
  • Europe
  • America
  • International
  • Submit Article
  • Other
    • Health
    • Tech
    • Travel
    • Science
No Result
View All Result
Londoner News
No Result
View All Result
Home Markets

RBI limits total outstanding ECBs to 6.5% of GDP

by The Editor
December 21, 2018
in Markets
0
RBI limits total outstanding ECBs to 6.5% of GDP
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

MUMBAI: The Reserve Bank of India (RBI) Thursday announced a cap on the outstanding stock of external commercial borrowings (ECB) at 6.5 per cent of GDP at current market prices.

Based on the gross domestic product (GDP) figures at March-end 2018, the soft limit works out to USD 160 billion for the current financial year, the RBI said in a statement.

"The outstanding stock of ECB as on September 30, 2018, stood at USD 126.29 billion," it said.

The decision to have a "rule-based dynamic limit" for outstanding stock of ECB at 6.5 per cent of GDP at current market prices has been taken in consultation with the government, the RBI added.

ECBs refer to commercial loans in the form of bank loans, securitised instruments (floating rate notes and fixed rate bonds, non-convertible, optionally convertible or partially convertible preference shares), buyers' credit, suppliers' credit availed of from non-resident lenders with a minimum average maturity of 3 years.

Original Article

[contf] [contfnew]

ET Markets

[contfnewc] [contfnewc]

The Editor

Next Post
Market outlook: Nifty stares at possible consolidation; 100-DMA remains key

Market outlook: Nifty stares at possible consolidation; 100-DMA remains key

Recommended

US stocks slide to biggest loss under Trump presidency on inflation fears

US stocks slide to biggest loss under Trump presidency on inflation fears

7 years ago
Coronavirus: WHO halts trials of hydroxychloroquine over safety fears

Coronavirus: WHO halts trials of hydroxychloroquine over safety fears

5 years ago

Popular News

    Connect with us

    About Us

    We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc. Check our landing page for details.

    Category

    • America
    • Britain
    • Entertainment
    • Europe
    • Health
    • International
    • latest news
    • London
    • Markets
    • Science
    • Tech
    • Travel
    • Uncategorized
    • Women

    Site Links

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • About
    • Contact

    © 2020 londonernews

    No Result
    View All Result
    • Home
    • Science
    • Travel
    • Tech
    • Health

    © 2020 londonernews